Jaykay Enterprises' Subsidiary Secures ₹94.45 Crore Contract from BrahMos Aerospace

1 min read     Updated on 18 Sept 2025, 03:06 PM
scanx
Reviewed by
Jubin VergheseScanX News Team
whatsapptwittershare
Overview

Allen Reinforced Plastics Limited, a step-down subsidiary of Jaykay Enterprises Limited, has converted a Letter of Intent into a definitive order from BrahMos Aerospace Private Limited. The contract, valued at approximately ₹94.45 crores (including GST), is for manufacturing composite parts for BrahMos Aerospace. This domestic order marks a significant achievement for Jaykay Enterprises in the aerospace manufacturing sector. The company disclosed this development in compliance with SEBI regulations, confirming it is not a related party transaction.

19733785

*this image is generated using AI for illustrative purposes only.

Jaykay Enterprises Limited has announced a significant business development in the aerospace sector. The company's step-down subsidiary, Allen Reinforced Plastics Limited (formerly Allen Reinforced Plastics Private Limited), has successfully converted a Letter of Intent (LOI) into a definitive order from BrahMos Aerospace Private Limited.

Contract Details

The contract, valued at approximately ₹94.45 crores (including GST), involves the manufacture of composite parts for BrahMos Aerospace. This domestic order represents a notable achievement for Jaykay Enterprises in the highly specialized field of aerospace manufacturing.

Key Points of the Order

Aspect Details
Client BrahMos Aerospace Private Limited
Nature of Work Manufacture of Composite Parts
Contract Value Approx. ₹94.45 crores (including GST)
Execution Timeline As per the terms and conditions specified in the order

Company Disclosure

Jaykay Enterprises made this disclosure in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that this contract does not fall under related party transactions, and there is no interest from the Promoter/Promoter Group/Group Companies in BrahMos Aerospace Private Limited.

Implications for Jaykay Enterprises

This contract marks a significant milestone for Jaykay Enterprises and its subsidiary in the aerospace sector. The substantial value of the order could potentially boost the company's revenue and strengthen its position in the manufacturing of specialized components for the aerospace industry.

The successful conversion of the LOI to a firm order also demonstrates the company's capability to meet the stringent requirements of high-profile clients in the aerospace sector, potentially opening doors for future opportunities in this domain.

Investors and stakeholders will likely be watching closely to see how this contract impacts Jaykay Enterprises' financial performance in the coming quarters, as well as any potential follow-on orders or expansion in the aerospace manufacturing segment.

Historical Stock Returns for Jaykay Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+14.57%+16.57%+21.72%+45.73%+100.49%+8,981.28%
Jaykay Enterprises
View in Depthredirect
like16
dislike

Jaykay Enterprises Subsidiary Inks Deal for Indigenous 3D-Printed Orthopedic Implants

1 min read     Updated on 10 Sept 2025, 12:47 PM
scanx
Reviewed by
Radhika SahaniScanX News Team
whatsapptwittershare
Overview

JK Digital & Advance Systems, a subsidiary of Jaykay Enterprises, has signed a Transfer of Technology Agreement with CSIO Chandigarh for manufacturing advanced 3D-printed lattice orthopedic implants. The 7-year deal covers seven orthopedic implant technologies for spinal and hip surgeries. This move aims to reduce import dependence and support India's 'Make in India' initiative in healthcare. Jaykay Enterprises becomes one of the first Indian companies to offer domestically produced 3D-printed lattice medical implants at affordable costs.

19034261

*this image is generated using AI for illustrative purposes only.

Jaykay Enterprises Limited's wholly owned subsidiary, JK Digital & Advance Systems Private Limited, has executed a Transfer of Technology (ToT) Agreement with the Central Scientific Instruments Organisation (CSIO), Chandigarh, for the indigenous manufacturing of advanced 3D-printed lattice orthopedic implants using additive manufacturing technology.

Key Highlights of the Agreement

  • The agreement covers seven state-of-the-art orthopedic implant technologies, primarily for spinal and hip surgeries.
  • Technologies include TLIF, PLIF, Buttress & Shim Augments, Shell & Wedge Augments, Lattice Cones, Cage Constructs, and Lattice Acetabular Cups.
  • The deal grants rights to utilize the technology for a period of 7 years.
  • Aims to reduce reliance on imports and support the Government of India's 'Make in India' initiative in the healthcare sector.

Significance for Jaykay Enterprises

This collaboration positions Jaykay Enterprises as one of the first Indian companies to offer indigenously manufactured 3D-printed lattice medical implants at affordable costs. The move aligns with the company's long-term strategy of advancing affordable healthcare solutions through indigenous innovation and technology leadership.

Impact on Indian Healthcare

The agreement is expected to strengthen India's medical device ecosystem with globally benchmarked, advanced technologies. By enabling domestic production of high-value implants, it aims to reduce the country's dependence on imports for these critical medical devices.

Market Implications

While the financial details of the agreement were not disclosed, this strategic move could potentially open up new revenue streams for Jaykay Enterprises in the growing medical devices market. The company's entry into advanced orthopedic implant manufacturing aligns with the increasing demand for cutting-edge medical technologies in India.

Future Outlook

As Jaykay Enterprises ventures into the high-tech medical devices sector, it will be interesting to observe how this diversification impacts the company's overall business performance and market position. The success of this initiative could pave the way for further innovations and partnerships in the healthcare technology space.

Investors and industry observers will likely keep a close watch on the implementation of this technology transfer and its potential to create value for Jaykay Enterprises and its stakeholders in the long run.

Historical Stock Returns for Jaykay Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
+14.57%+16.57%+21.72%+45.73%+100.49%+8,981.28%
Jaykay Enterprises
View in Depthredirect
like20
dislike
More News on Jaykay Enterprises
Explore Other Articles
184.35
+23.45
(+14.57%)